Literature DB >> 9766455

Self-report and polysomnographic measures of sleep in women with irritable bowel syndrome.

M Heitkemper1, A B Charman, J Shaver, M J Lentz, M E Jarrett.   

Abstract

BACKGROUND: Women who report chronic gastrointestinal symptoms compatible with a diagnosis of irritable bowel syndrome (IBS) frequently report sleep disturbances.
OBJECTIVES: The purposes of this study were to (a) compare self-reported and polysomnographic indicators of sleep quality in women with IBS symptoms (IBS-SX, n= 16) and controls (n= 16); (b) examine the relationship between the indicators of sleep quality; and (c) determine the relationship between sleep indicators and psychological distress.
METHOD: The women slept in a laboratory for 2 consecutive nights. Polysomnographic measurements were recorded during sleep, and a sleep questionnaire was completed upon awakening each morning. Psychological distress was measured with the Symptom Checklist-90-R during the initial interview.
RESULTS: Women in the IBS-SX group reported significantly greater numbers of awakenings during sleep (p = .008) and had a longer latency to REM sleep (p = .04) than did the controls. Self-reported and polysomnographic indicators were more highly correlated in the control group than in the IBS-SX group. In the IBS-SX group, the greater the psychological distress, the less alert (rs = .419) and rested (rs = .564) the women felt in the morning and the more time the women spent in stages 3 and 4 sleep (rs = .479) and less in stage 2 (rs = -.447) and REM (rs = -.414) sleep. In the control group, psychological distress was not significantly associated with self-reported measures but was significantly associated with the number of awakenings (rs = .506) and time in stages 3 and 4 sleep (rs = -.677).
CONCLUSIONS: Although the women in the IBS-SX group reported significantly more awakenings, the weak relationship between self-reported and polysomnographic indicators suggests that clinicians must keep in mind that further assessments may be necessary.

Entities:  

Mesh:

Year:  1998        PMID: 9766455     DOI: 10.1097/00006199-199809000-00006

Source DB:  PubMed          Journal:  Nurs Res        ISSN: 0029-6562            Impact factor:   2.381


  4 in total

1.  Melatonin: a novel treatment for IBS?

Authors:  S Elsenbruch
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

2.  Modulation of sleep quality and autonomic functioning by symptoms of depression in women with irritable bowel syndrome.

Authors:  Jennifer J T Robert; William C Orr; Sigrid Elsenbruch
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

3.  Sleep quality, BDNF genotype and gene expression in individuals with chronic abdominal pain.

Authors:  Swarnalatha Y Reddy; Nat A Rasmussen; Nicolaas H Fourie; Rebecca S Berger; Angela C Martino; Jessica Gill; Ryan Longchamps; Xiao Min Wang; Margaret M Heitkemper; Wendy A Henderson
Journal:  BMC Med Genomics       Date:  2014-10-31       Impact factor: 3.063

4.  Psychosocial factors at work and in every day life are associated with irritable bowel syndrome.

Authors:  Ashild Faresjö; Ewa Grodzinsky; Saga Johansson; Mari-Ann Wallander; Toomas Timpka; Ingemar Akerlind
Journal:  Eur J Epidemiol       Date:  2007-05-05       Impact factor: 12.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.